Translational Science Lead, Translational Medicine Oncology @ Translational Medicine Lead:Generate and integrate biomarker approaches to project progression from preclinical to clinical stages of drug development. Responsible for conception and execution of translational hypothesis to support differentiation and rational combinations of immuno-oncology targets (eg. PD-L1, PD1, OX40, CD73).Communicate and interact effectively in cross functional teams such as research, clinical and regulatory project teams as well as external collaborators and CROs. Participate in training for clinical site initiation for Ph1 trial to ensure that sites are informed on the purpose and preparation of the samples collected for biomarker analyses. Scientific Research:Scientific lead who performed independent and collaborative research resulting in peer-reviewed publications and presentations at international cancer conferences. Experienced in area of angiogenesis, signaling, antibody drug conjugate, immunotherapy and apoptosis. Management Experience: Hired, supervised and mentored research associates and interns. Provided access to teams in a cross-functional organization and created opportunities for increased visibility and career. From 2006 to Present (9 years) Post Doc @ From 2002 to 2006 (4 years) PhD @ From 1996 to 2002 (6 years)

PhD, Molecular and Medical Genetics; Developmental Biology @ University of Toronto Ching Leow is skilled in: Drug Discovery, Assay Development, Molecular Biology, Biotechnology, Drug Development, ELISA, Immunology, Cell Culture, Lifesciences, Cell, Cell Biology, Pharmacology, Cancer Immunotherapy, Life Sciences, Cancer, Oncology